Atlas Trials

Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

Clinical trial NCT00062270 · COMPLETED

Trial details

NCT number
NCT00062270
Sponsor
University of Alabama at Birmingham
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2003-05-01
Primary completion
2004-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.